Patients With HR+ Breast Cancer May Safely Pause Endocrine Therapy to Pursue Pregnancy
The short-time period recurrence charges ended up similar between people with early-phase hormone receptor–positive breast
The short-time period recurrence charges ended up similar between people with early-phase hormone receptor–positive breast
The first review to handle head-on a major situation for young breast cancer survivors —